As Dry Eye Awareness Month kicks off, Bausch + Lomb is rolling out a new campaign to improve education about the condition. More: Bausch + Lomb builds out dry eye awareness push with new survey, patient stories Source: fierce
read moreKKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker into a fast-growing business for the past five years. More: Torrent Pharma shells out .4B to take over controlling stake in
read moreIn a quarterly update, the FDA said it’s evaluating the need for regulatory action on argenx’s Vyvgart Hytrulo after observing a potential signal of “severe worsening” of CIDP. But analysts are brushing off the risk. More: FDA weighs regulatory action
read moreApellis and Sobi have amended their partnership agreement for paroxysmal nocturnal hemoglobinuria treatment Empaveli, or Aspaveli as it is known in Europe. With the new deal, Stockholm-based Sobi agreed to pay $275 million upfront and up to $25 million in
read more
Data shows mRNA-1010 could better protect adults aged 50 and above More: Moderna flu vaccine shows superior results in phase 3 study Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals